Deferiprone in Alzheimer Disease: A Randomized Clinical Trial.
Saved in:
| Title: | Deferiprone in Alzheimer Disease: A Randomized Clinical Trial. |
|---|---|
| Authors: | Ayton S; The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia.; Florey Department of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia., Barton D; NeuroCentrix, Carlton, Australia., Brew B; Department of Neurology and Peter Duncan Neurosciences Research Unit, St Vincent's Hospital, Darlinghurst, Australia.; University of New South Wales, Sydney, Australia., Brodtmann A; The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia.; Department of Neuroscience, School of Translational Medicine, Monash University, Melbourne, Australia., Clarnette R; Curtin Health Innovation Research Institute, Curtin University, Bentley, Australia., Desmond P; Department of Radiology, Royal Melbourne Hospital, The University of Melbourne, Parkville, Australia., Devos D; Department of Medical Pharmacology, Expert Center of Parkinson's Disease, ALS, and Neurogenetics, University of Lille, Lille Neuroscience & Cognition Research Center, Lille, France., Ellis KA; Department of Psychiatry, Melbourne School of Psychological Sciences, The University of Melbourne, Parkville, Australia., Fazlollahi A; Department of Radiology, Royal Melbourne Hospital, The University of Melbourne, Parkville, Australia.; Queensland Brain Institute, The University of Queensland, Brisbane, Australia., Fradette C; Chiesi Global Rare Diseases, Chiesi Canada Corporation, Woodbridge, Canada., Goh AMY; National Ageing Research Institute, The University of Melbourne, Parkville, Australia., Kalinowski P; The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia., Kyndt C; Melbourne Health Cognitive Neurology Clinic, The Royal Melbourne Hospital, Parkville, Australia., Lai R; KaRa Institute of Neurological Diseases, Macquarie Park, Australia., Lim YY; School of Psychological Sciences, Monash University, Melbourne, Australia.; Turner Institute for Brain and Mental Health, Monash University, Melbourne, Australia., Maruff P; The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia.; Cogstate Ltd, Melbourne, Australia., O'Brien TJ; Department of Neuroscience, School of Translational Medicine, Monash University, Melbourne, Australia., Rowe C; The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia.; Austin Health, The University of Melbourne, Parkville, Australia., Salvado O; Data61, Commonwealth Scientific and Industrial Research Organization, Eveleigh, Australia., Schofield PW; Neuropsychiatry Service, Hunter New England Local Health District, Newcastle, Australia.; University of Newcastle, Callaghan, Australia., Spino M; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada., Tricta F; Chiesi Global Rare Diseases, Chiesi Canada Corporation, Woodbridge, Canada., Wagen A; Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, United Kingdom.; The Francis Crick Institute, London, United Kingdom.; Department of Genetics and Genomic Medicine, Great Ormond Street Institute of Child Health, University College London, London, United Kingdom., Williams R; The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia.; National Imaging Facility, St Lucia, Australia., Woodward M; Austin Health, The University of Melbourne, Parkville, Australia., Bush AI; The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia.; Florey Department of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia. |
| Source: | JAMA neurology [JAMA Neurol] 2025 Jan 01; Vol. 82 (1), pp. 11-18. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Multicenter Study |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101589536 Publication Model: Print Cited Medium: Internet ISSN: 2168-6157 (Electronic) Linking ISSN: 21686149 NLM ISO Abbreviation: JAMA Neurol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2168-6157 |
|---|---|
| DOI: | 10.1001/jamaneurol.2024.3733 |
